OFIX – Orthofix Medical Inc
OFIX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
6.07
Margin Of Safety %
Put/Call OI Ratio
2.88
EPS Next Q Diff
0.74
EPS Last/This Y
2.74
EPS This/Next Y
-0.04
Price
9.81
Target Price
13
Analyst Recom
1.5
Performance Q
-17.56
Upside
-645.9%
Beta
0.65
Ticker: OFIX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-09-28 | OFIX | 9.84 | 3.05 | 0.20 | 336 |
| 2026-09-29 | OFIX | 9.76 | 2.92 | 1.67 | 341 |
| 2026-09-30 | OFIX | 9.43 | 2.92 | 1.67 | 341 |
| 2026-10-01 | OFIX | 9.23 | 2.92 | 1.67 | 341 |
| 2026-10-02 | OFIX | 9.1 | 2.92 | 1.67 | 341 |
| 2026-10-05 | OFIX | 9.49 | 2.92 | 1.67 | 341 |
| 2026-10-06 | OFIX | 9.42 | 2.92 | 1.67 | 341 |
| 2026-10-07 | OFIX | 9.2 | N/A | N/A | 0 |
| 2026-10-08 | OFIX | 9 | N/A | N/A | 0 |
| 2026-10-09 | OFIX | 9.17 | 2.86 | 0.00 | 336 |
| 2026-10-12 | OFIX | 9.3 | 2.86 | 0.00 | 336 |
| 2026-10-13 | OFIX | 9.27 | 2.86 | 0.00 | 336 |
| 2026-10-14 | OFIX | 9.24 | 2.86 | 0.00 | 336 |
| 2026-10-15 | OFIX | 9.59 | 2.86 | 999.99 | 336 |
| 2026-10-16 | OFIX | 9.4 | 2.86 | 999.99 | 336 |
| 2026-10-19 | OFIX | 9.6 | 2.78 | 0.00 | 329 |
| 2026-10-20 | OFIX | 9.86 | 2.78 | 0.00 | 329 |
| 2026-10-21 | OFIX | 9.76 | 2.88 | 0.00 | 326 |
| 2026-10-22 | OFIX | 9.98 | 2.88 | 0.00 | 326 |
| 2026-10-23 | OFIX | 9.81 | 2.88 | 0.00 | 326 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-09-28 | OFIX | 9.84 | -44.3 | - | 0.41 |
| 2026-09-29 | OFIX | 9.76 | -44.3 | - | 0.41 |
| 2026-09-30 | OFIX | 9.44 | -44.3 | - | 0.41 |
| 2026-10-01 | OFIX | 9.23 | -44.3 | - | 0.41 |
| 2026-10-02 | OFIX | 9.09 | -44.3 | - | 0.41 |
| 2026-10-05 | OFIX | 9.50 | -44.3 | - | 0.41 |
| 2026-10-06 | OFIX | 9.43 | -44.3 | - | 0.41 |
| 2026-10-07 | OFIX | 9.20 | -44.3 | - | 0.41 |
| 2026-10-08 | OFIX | 9.01 | -44.3 | - | 0.41 |
| 2026-10-09 | OFIX | 9.17 | -44.3 | - | 0.41 |
| 2026-10-12 | OFIX | 9.29 | -44.3 | - | 0.41 |
| 2026-10-13 | OFIX | 9.27 | -44.3 | - | 0.41 |
| 2026-10-14 | OFIX | 9.24 | -44.3 | - | 0.41 |
| 2026-10-15 | OFIX | 9.59 | -44.3 | - | 0.41 |
| 2026-10-16 | OFIX | 9.40 | -44.3 | - | 0.41 |
| 2026-10-19 | OFIX | 9.61 | -44.3 | - | 0.41 |
| 2026-10-20 | OFIX | 9.61 | -44.3 | - | 0.41 |
| 2026-10-21 | OFIX | 9.86 | -44.3 | - | 0.41 |
| 2026-10-22 | OFIX | 9.98 | -44.3 | - | 0.41 |
| 2026-10-23 | OFIX | 9.81 | -44.3 | - | 0.41 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-09-28 | OFIX | 58.06 | 2.64 | 6.23 |
| 2026-09-29 | OFIX | 58.06 | 2.64 | 6.23 |
| 2026-09-30 | OFIX | 58.06 | 2.64 | 6.23 |
| 2026-10-01 | OFIX | 58.06 | 2.64 | 6.23 |
| 2026-10-02 | OFIX | 58.06 | 2.64 | 6.23 |
| 2026-10-05 | OFIX | 58.06 | 2.60 | 6.23 |
| 2026-10-06 | OFIX | 57.98 | 2.60 | 6.23 |
| 2026-10-07 | OFIX | 57.98 | 2.60 | 6.23 |
| 2026-10-08 | OFIX | 57.98 | 2.60 | 6.23 |
| 2026-10-09 | OFIX | 57.98 | 2.60 | 6.23 |
| 2026-10-12 | OFIX | 57.98 | 2.83 | 6.07 |
| 2026-10-13 | OFIX | 57.98 | 2.83 | 6.07 |
| 2026-10-14 | OFIX | 57.98 | 2.83 | 6.07 |
| 2026-10-15 | OFIX | 57.98 | 2.83 | 6.07 |
| 2026-10-16 | OFIX | 57.98 | 2.83 | 6.07 |
| 2026-10-19 | OFIX | 57.99 | 2.64 | 6.07 |
| 2026-10-20 | OFIX | 57.99 | 2.64 | 6.07 |
| 2026-10-21 | OFIX | 59.90 | 2.64 | 6.07 |
| 2026-10-22 | OFIX | 59.90 | 2.64 | 6.07 |
| 2026-10-23 | OFIX | 59.90 | 2.64 | 6.07 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.39
Avg. EPS Est. Current Quarter
0.11
Avg. EPS Est. Next Quarter
0.35
Insider Transactions
59.9
Institutional Transactions
2.64
Beta
0.65
Average Sales Estimate Current Quarter
210
Average Sales Estimate Next Quarter
232
Fair Value
Quality Score
50
Growth Score
54
Sentiment Score
59
Actual DrawDown %
74.7
Max Drawdown 5-Year %
-77.6
Target Price
13
P/E
Forward P/E
PEG
P/S
0.48
P/B
0.93
P/Free Cash Flow
EPS
-1.53
Average EPS Est. Cur. Y
0.41
EPS Next Y. (Est.)
0.37
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-7.41
Relative Volume
0.65
Return on Equity vs Sector %
-40
Return on Equity vs Industry %
-25.4
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.11
EBIT Estimation
◆
OFIX
Healthcare
$9.81
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
56.6
Range 1M
77.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
49.6%
EPS NY
19.6%
52W%
15.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+32.1% upside
Upside
+32.1%
Quality
50
OFIX — P/E HistoricalMedical Devices
Orthofix Medical Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 1605
Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
OFIX
Latest News
—
Caricamento notizie per OFIX…
stock quote shares OFIX – Orthofix Medical Inc Stock Price stock today
news today OFIX – Orthofix Medical Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch OFIX – Orthofix Medical Inc yahoo finance google finance
stock history OFIX – Orthofix Medical Inc invest stock market
stock prices OFIX premarket after hours
ticker OFIX fair value insiders trading